HomeNewsWorld NewsFTC Settles With Amgen Over $27.8 Billion Deal for Horizon Therapeutics

FTC Settles With Amgen Over $27.8 Billion Deal for Horizon Therapeutics

The Federal Trade Commission reached a settlement with Amgen that would allow the drugmaker to acquire Horizon Therapeutics and dismisses the antitrust claims of six states.

Leave a Reply

Your email address will not be published. Required fields are marked *

Disclaimer:

Copyright: © 2023 iSeekFX. All Rights Reserved.